Ernst & Young LLP (EY) will work with India Glycols Limited in identifying and evaluating various options and opportunities including restructuring of businesses of the company with the objective to unlock stakeholders’ value.

On 29th July, 2024, India Glycols Limited constituted a committee of directors to examine, inter-alia, the company's current position and business strategy for enhancing stakeholders value. Today, India Glycols Limited in its Board meeting has appointed EY as its financial and tax consultant in this regard.

The financial and tax consultant is expected to present its report and findings in this regard in Q3 of FY25.

IGL has a global presence and partners in various countries, which makes the company an inclusive and diverse enterprise. With an impressive portfolio of pharmaceutical, food and beverage, personal care, and industrial sector products, the company touches lives every day and everywhere.